Now showing items 1-6 of 6
Time trends and educational inequalities in out-of-hospital coronary deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) project
(American Heart Association, 2017-02)
Background: Recent time trends and educational gradients characterizing out‐of‐hospital coronary deaths (OHCD) are poorly described. Methods and Results: We identified all deaths from coronary heart disease occurring ...
Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project
Background: Coronary heart disease (CHD) represents often the underlying conditions for the development of heart failure (HF). We aimed at exploring the burden and timing of HF complicating an acute myocardial infarction ...
Periconceptional Folic Acid Supplementation and Infant Risk of Congenital Heart Defects in Norway 1999-2009
(John Wiley & Sons Ltd., 2015-07-24)
Background The birth prevalence of congenital heart defects (CHDs) has decreased in Canada and Europe. Recommended intake of folic acid in pregnancy is a suggestive risk-reducing factor for CHDs. We investigated the ...
Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project
Background: Heart failure (HF) is a serious complication of acute myocardial infarction (AMI). We explored the excess mortality associated with HF as an early or late complication of AMI and describe changes over time in ...
Musculoskeletal disorders in Norway: Prevalence of chronicity and use of primary and specialist health care services
(BioMed Central, 2015-04-02)
Background: Uncertainty exists with regards to the extent of prevalence and health care use for musculoskeletal disorders in Norway. The aim of this study was to estimate the prevalence of chronic musculoskeletal disorders ...
Are the Norwegian health research investments in line with the disease burden?
(BioMed Central, 2014-11-27)
Background: The relationship between research funding across therapeutic areas and the burden of disease in Norway has not been investigated. Further, few studies have looked at the association between national research ...